Cargando…
Missed detection of significant positive and negative shifts in gentamicin assay: implications for routine laboratory quality practices
INTRODUCTION: A product recall was issued for the Roche/Hitachi Cobas Gentamicin II assays on 25(th) May 2016 in Australia, after a 15 - 20% positive analytical shift was discovered. Laboratories were advised to employ the Thermo Fisher Gentamicin assay as an alternative. Following the reintroductio...
Autores principales: | Koerbin, Gus, Liu, Jiakai, Eigenstetter, Alex, Tan, Chin Hon, Badrick, Tony, Loh, Tze Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Society of Medical Biochemistry and Laboratory Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701776/ https://www.ncbi.nlm.nih.gov/pubmed/29187798 http://dx.doi.org/10.11613/BM.2018.010705 |
Ejemplares similares
-
Gamma-Glutamyl Transferase (GGT) Is the Leading External Quality Assurance Predictor of ISO15189 Compliance for Pathology Laboratories
por: Lidbury, Brett A., et al.
Publicado: (2021) -
Patient-based quality control for glucometers: using the moving sum of positive patient results and moving average
por: Lim, Chun Yee, et al.
Publicado: (2020) -
Opinion Paper: Deriving Harmonised Reference Intervals – Global Activities
por: Tate, Jillian R., et al.
Publicado: (2016) -
Impact of combining data from multiple instruments on performance of patient-based real-time quality control
por: Zhou, Qianqian, et al.
Publicado: (2021) -
Paraprotein interference with turbidimetric gentamicin assay
por: Dimeski, Goce, et al.
Publicado: (2015)